Nabriva Therapeutics plc Operating Leases, Future Minimum Payments Due
Nabriva Therapeutics plc had Operating Leases, Future Minimum Payments Due of $743.00 thousand as of 2020-12-31, per its 10-K filed 2021-03-11.
Discontinued › Notes › Leases
us-gaap:OperatingLeasesFutureMinimumPaymentsDue · last filed 2021-03-11
- 2020-12-31: Operating Leases, Future Minimum Payments Due $743.00K.
- 2019-12-31: Operating Leases, Future Minimum Payments Due $3.22M.
- 2018-12-31: Operating Leases, Future Minimum Payments Due $1.54M; Operating Leases, Future Minimum Payments Due as first filed $3.51M.
- 2017-12-31: Operating Leases, Future Minimum Payments Due $3.33M.
| Period end | Operating Leases, Future Minimum Payments Due | Operating Leases, Future Minimum Payments Due as first filed |
|---|---|---|
| 2020-12-31 | $743.00K 10-K · filed 2021-03-11 | |
| 2019-12-31 | $3.22M 10-K · filed 2020-03-12 | |
| 2018-12-31 | $1.54M 10-Q · filed 2019-11-12 | $3.51M 10-K · filed 2019-03-12 |
| 2017-12-31 | $3.33M 10-K · filed 2018-03-16 | |
| 2017-09-30 | $3.44M 10-Q · filed 2017-11-09 | |
| 2017-06-30 | $3.83M 10-Q · filed 2017-08-07 | |
| 2017-03-31 | $4.34M 10-Q · filed 2017-05-10 | |
| 2016-12-31 | $4.53M 10-Q · filed 2017-11-09 | |
| 2015-12-31 | $6.10M 10-K · filed 2017-03-24 |